Affiliate of Green Leaf Pharmaceutical (02186) has completed the issuance of 1.5 million shares of convertible preferred stock.

Smart Financial News APP, Luye Pharmaceuticals (02186) announced that on December 12, 2025, the issuance of convertible preferred shares in accordance with the terms of the subscription agreement has been completed. The issuer, Luye Geneora Holding Limited (a wholly-owned subsidiary of our company), has allocated and issued 1.5 million convertible preferred shares to subscribers.